from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2495c/bkdC

LFCtreatmentdescriptionclass of inhibitor

-1.583

Amikacinug/mL Amikacintranslation

-2.027

Cap5-10ug/mL Capreomycintranslation

-2.854

Rox10-50 ug/mL Roxithromycintranslation

-0.883

SM2-5 ug/mL Streptomycintranslation

-1.707

Tet5-10 ug/mL Tetracyclinetranslation

0.231

Rif0.2-5ug/mL Rifampicintranscription

-0.475

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.626

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.771

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.613

CPZ10-50 ug/mL Chlorpromazinerespiration

0.472

Clofazimine10-13 ug/mL Clofaziminerespiration

0.014

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.923

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.358

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.014

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.216

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.043

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.725

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.058

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.188

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.318

KCN5-20 ug/mL Potassium cyaniderespiration

0.521

NaN30.2-2 mM Sodium aziderespiration

0.170

Nigericin50 uM Nigericinrespiration

1.288

TRC10-150 ug/mL Triclosanrespiration

0.724

TRZ10-25 ug/mL Thioridazinerespiration

0.263

Valinomycin0.5-10 uM Valinomycinrespiration

0.059

ZnSO42 mM ZnSO4respiration

0.066

menadione6-10 ug/mL Menadionerespiration

-0.592

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.399

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.554

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.473

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.361

NRP_1Non-replicating persistence stage 1dosRassociated

-0.440

Amp0.2mg/mL AmpicillincellWall

-0.039

Cephalexin20-100 ug/mL CephalexincellWall

-0.669

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.205

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.126

EMB10-20 ug/mL EthambutolcellWall

-0.548

Eta12-40 ug/mL EthionamidecellWall

-0.826

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.291

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.401

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.458

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.388

BZA0.12 mg/mL BenzamidearomaticAmides

0.004

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.603

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.239

H2O24 mM hydrogen peroxideDNAdamaging

-0.985

Levo10 ug/mL LevofloxacinDNAdamaging

-0.219

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.267

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.405

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.237

UVUV-irradiationDNAdamaging

0.261

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.553

Antimycin12.5-50 ug/mL Antimycin A?

-0.079

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.212

PA_110-50 ug/mL Antitubercular compound PA-1?

0.197

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.255

PA8240.2-2 ug/mL PA-824?

1.709

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.298

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.216

Verapamil50 uM Verapamil?

0.287

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.366

methoxatin10-20 ug/mL Methoxatin?